Literature DB >> 7318147

Human tumor cloning: feasibility and clinical correlations.

D D Von Hoff, J Cowan, G Harris, G Reisdorf.   

Abstract

The human tumor cloning system is a soft agar technique which allows the growth of human tumors in vitro. We report here our experience with culturing 2,365 patients' tumors in the system. Overall 1,844 (78%) have formed colonies in vitro. However, only 51% have formed greater than or equal to 30 colonies per 500,000 cells plated. Despite the limitations of inadequate growth for some tumors there are a number of clinical applications for the system, which are reported here. These include: (1) Use of the system to predict for sensitivity of an individual patient's tumor to a particular chemotherapeutic agent; (2) screening new anticancer agents to predict for in vivo activity; 3) monitoring patients' bone marrows for tumor involvement; and (4) use of the number of colonies which form in the assay as a prognostic factor for survival. All of these clinical applications are in their infancy of development and will require carefully designed prospective trials to determine the final place of the human tumor cloning system in the practice of clinical oncology.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7318147     DOI: 10.1007/bf00256979

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  11 in total

1.  Direct cloning of human ovarian carcinoma cells in agar.

Authors:  A W Hamburger; S E Salmon; M B Kim; J M Trent; B J Soehnlen; D S Alberts; H J Schmidt
Journal:  Cancer Res       Date:  1978-10       Impact factor: 12.701

2.  Primary bioassay of human myeloma stem cells.

Authors:  A Hamburger; S E Salmon
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

3.  Clonogenic assay and in vitro chemosensitivity testing of human urologic malignancies.

Authors:  M F Sarosdy; D L Lamm; H M Radwin; D D Von Hoff
Journal:  Cancer       Date:  1982-10-01       Impact factor: 6.860

4.  Direct cloning of human neuroblastoma cells in soft agar culture.

Authors:  D D Von Hoff; J Casper; E Bradley; J M Trent; A Hodach; C Reichert; R Makuch; A Altman
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

5.  Direct cloning of human parathyroid hyperplasia cells in soft-agar culture.

Authors:  E C Bradley; C M Reichert; M F Brennan; D D Von Hoff
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

6.  In vitro stem cell assay in head and neck squamous carcinoma.

Authors:  D E Mattox; D D Von Hoff
Journal:  Am J Surg       Date:  1980-10       Impact factor: 2.565

7.  Activity of mitoxantrone in a human tumor cloning system.

Authors:  D D Von Hoff; C A Coltman; B Forseth
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

8.  Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.

Authors:  S E Salmon; A W Hamburger; B Soehnlen; B G Durie; D S Alberts; T E Moon
Journal:  N Engl J Med       Date:  1978-06-15       Impact factor: 91.245

9.  Primary bioassay of human tumor stem cells.

Authors:  A W Hamburger; S E Salmon
Journal:  Science       Date:  1977-07-29       Impact factor: 47.728

10.  Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy.

Authors:  D D Von Hoff; J Casper; E Bradley; J Sandbach; D Jones; R Makuch
Journal:  Am J Med       Date:  1981-05       Impact factor: 4.965

View more
  22 in total

1.  A trial of the in vitro sensitivity test of anti-cancer drugs using primary cultured urogenital cancer cells.

Authors:  T Miura; Y Kubota; T Sakuramoto; M Hosaka
Journal:  Urol Res       Date:  1987

Review 2.  An assessment of current achievements in the systemic management of breast cancer.

Authors:  M E Lippman
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

3.  Enhancement of rat ACT-1 tumor clonogenicity by xenogeneic mouse macrophages.

Authors:  K W Beagley; L S Horne; R F Noronha; C M Goodall; C M Moore
Journal:  In Vitro       Date:  1984-08

Review 4.  The human tumor cloning assay in cancer drug development. A review.

Authors:  P Agre; T E Williams
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

5.  Short-term culture of pediatric brain tumors.

Authors:  W J Mackillop; J Blundell; P Steele
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

6.  Cell kinetics and in vitro clonogenicity of primary colorectal cancer: clinicopathological relationships and the implications for chemotherapy.

Authors:  G A Trotter; G R Morgan; A J Cooper; N Kirkham; J M Whitehouse; I Taylor
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

7.  Chemosensitivity assessed by collagen gel droplet embedded culture drug sensitivity test, and MDR1, MRP1, and MRP2 mRNA expression in human colorectal adenocarcinomas.

Authors:  Takako Nakahara; Toshiyuki Sakaeda; Tsutomu Nakamura; Takao Tamura; Chiharu Nishioka; Nobuo Aoyama; Noboru Okamura; Toshiro Shirakawa; Akinobu Gotoh; Takashi Kamigaki; Masakazu Ohno; Yoshikazu Kuroda; Masafumi Matsuo; Masato Kasuga; Katsuhiko Okumura
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

8.  Use of an efficient method for culturing human mammary epithelial cells to study adriamycin sensitivity.

Authors:  H S Smith; A J Hackett; S Lan; M R Stampfer
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

9.  The colony inhibition of a new chemotherapeutic agent (KW2152) against human lung cancer cell lines.

Authors:  J R Jett; N Saijo; W S Hong; Y Sasaki; H Takahashi; H Nakano; K Nakagawa; M Sakurai; K Suemasu; M Tesada
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

10.  Does in vitro colony formation and chemosensitivity relate to DNA ploidy and S-phase fractions?

Authors:  D Flentje; G Feichter; M Flentje; K L Krämer; K Goerttler; P Schlag
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.